Endpoint definition
↥Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to Melanocytic naevi of lower limb, including hip based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
All | Female | Male | |
---|---|---|---|
Number of individuals | 624 | 446 | 178 |
Unadjusted prevalence (%) | 0.24 | 0.30 | 0.16 |
Mean age at first event (years) | 47.73 | 46.25 | 51.43 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | 0.05 | 3.36 [1.88, 6.00] | 4.2e-5 | 28 |
15 years | 0.02 | 3.29 [1.80, 6.04] | 1.2e-4 | 24 |
5 years | 0.01 | 4.75 [2.23, 10.10] | 5.3e-5 | 10 |
1 year | - | - | - | - |
Index endpoint: CD2_BENIGN_MELANOCYTIC_LOWERLIMB – Melanocytic naevi of lower limb, including hip
GWS hits: 0
before Melanocytic naevi of lower limb, including hip
after Melanocytic naevi of lower limb, including hip
Loading survival analyses plot
Loading survival analyses table